Page last updated: 2024-08-16

pimobendan and angiotensin ii

pimobendan has been researched along with angiotensin ii in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kimura, T; Kuwashima, H; Matsumura, C	1
Matsumori, A	1
Endoh, M	1

Reviews

2 review(s) available for pimobendan and angiotensin ii

Article	Year
[Cytokine antagonists and endothelin antagonists for therapy of heart failure]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2 Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Bosentan; Clinical Trials as Topic; Cytokines; Endothelins; Etanercept; Genetic Therapy; Heart Failure; Humans; Immunoglobulin G; Infliximab; Interleukin-10; Mast Cells; NF-kappa B; Proto-Oncogene Proteins c-kit; Pyridazines; Receptors, Tumor Necrosis Factor; Sulfonamides	2005
Cardiac Ca2+ signaling and Ca2+ sensitizers. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:12 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Azocines; Calcium; Calcium Signaling; Cardiotonic Agents; Cholinergic Agonists; Dihydropyridines; Endothelins; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Quinolines; Simendan; Thiadiazines; Troponin C	2008

Article

Year

[Cytokine antagonists and endothelin antagonists for therapy of heart failure].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2

Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Bosentan; Clinical Trials as Topic; Cytokines; Endothelins; Etanercept; Genetic Therapy; Heart Failure; Humans; Immunoglobulin G; Infliximab; Interleukin-10; Mast Cells; NF-kappa B; Proto-Oncogene Proteins c-kit; Pyridazines; Receptors, Tumor Necrosis Factor; Sulfonamides

2005

Cardiac Ca2+ signaling and Ca2+ sensitizers.

Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:12

Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Azocines; Calcium; Calcium Signaling; Cardiotonic Agents; Cholinergic Agonists; Dihydropyridines; Endothelins; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Quinolines; Simendan; Thiadiazines; Troponin C

2008

Other Studies

1 other study(ies) available for pimobendan and angiotensin ii

Article	Year
Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells. Journal of pharmacological sciences, 2003, Volume: 91, Issue:3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Adrenal Glands; Amrinone; Angiotensin II; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dimethylphenylpiperazinium Iodide; Histamine; Isoquinolines; Milrinone; Potassium; Pyridazines; Sulfonamides	2003

Article

Year

Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells.

Journal of pharmacological sciences, 2003, Volume: 91, Issue:3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Adrenal Glands; Amrinone; Angiotensin II; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dimethylphenylpiperazinium Iodide; Histamine; Isoquinolines; Milrinone; Potassium; Pyridazines; Sulfonamides

2003